Trial intelligence / Profile preview

Famciclovir in Recurrent Genital Herpes (RELIEF)

NCT00219310Phase 4Completed

Sponsor
Novartis
Start
Jun 2003
Primary completion
Jun 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of famciclovir in genital herpes, sponsored by Novartis. Started Jun 2003; status: completed.

02

Drugs

famciclovir
03

Conditions

genital herpes

Beyond the preview

Go deeper on NCT00219310.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00219310.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call